Table 1.
Patients’ baseline characteristics. Summary of preoperative patients’ characteristics. Values are expressed as mean ± SD or as percentage (in brackets). Significant changes are displayed in italics. Abbreviations: ACE, angiotensin-converting enzyme; AT1, angiotensin-1; BMI, body mass index. Chi2 test was performed for categorial variables, and an unpaired, two-tailed t-test was applied for comparison of metric variables. Significant changes are displayed in italics.
| CTR | IDDM/NIDDM | p-Value | |
|---|---|---|---|
| Age (years) | 65.15 ± 9.08 | 66.90 ± 9.83 | 0.5782 |
| Female (%) | 61.54% | 61.11% | 0.9754 |
| Height (cm) | 1.694 ± 0.081 | 1.681 ± 0.104 | 0.5856 |
| Body weight (kg) | 80.62 ± 13.5 | 79.56 ± 12.6 | 0.7794 |
| BMI (ratio) | 27.99 ± 3.62 | 28.43 ± 5.60 | 0.7234 |
| Waist circumference (cm) | 102.4 ± 8.69 | 102.6 ± 9.53 | 0.9257 |
| Hip circumference (cm) | 100.5 ± 6.49 | 104.9 ± 8.59 | 0.1357 |
| Waist/Hip ratio | 1.018 ± 0.077 | 0.986 ± 0.096 | 0.3452 |
| Oral anti-diabetics (%) | 0.00% | 88.89% | <0.0001 |
| Insulin dependence (%) | 0.00% | 16.67% | 0.0088 |
| ACE inhibitors (%) | 35.90% | 50.00% | 0.3131 |
| AT1 antagonists (%) | 12.82% | 22.22% | 0.3656 |
| Beta-blocker (%) | 58.97% | 55.56% | 0.8080 |
| Calcium-channel blocker/%) | 20.51% | 16.67% | 0.7323 |
| Spironolactone (%) | 2.56% | 0.00% | 0.4931 |
| Statins (%) | 64.10% | 50.00% | 0.3131 |